FURTHER EVIDENCE SUPPORTING THE USE OF LETERMOVIR FOR CMV PROPHYLAXIS - IT'S NOT ONLY LEUKOPENIA [0.03%]
进一步支持使用Letermovir预防CMV的研究——不仅仅是白细胞减少症的作用
Ilkka Helanterä,Anders Åsberg
Ilkka Helanterä
Comment on: Associations Between Donor-derived Cell-free DNA Dynamics and Clinical Outcomes After Kidney Allograft Rejection: A Prospective, Multi-center Study [0.03%]
评论：供体来源的游离DNA动力学与肾移植排异反应后临床结果的关系：一项前瞻性的多中心研究
Sook H Park,John J Friedewald
Sook H Park
Probable reactivation from latency of multi-drug resistant cytomegalovirus in a lung transplant recipient: a case report [0.03%]
肺移植受者潜伏多药耐药巨细胞病毒再激活的个案报道
Julia A Wagner,Rama Yakubu,Adrian M Whelan et al.
Julia A Wagner et al.
Whether ganciclovir-resistant cytomegalovirus (ganR-CMV) can establish latency and reactivate absent any selective drug pressure is unknown and has implications for selecting empiric antiviral therapy in patients with prior ganR-CMV. A CMV-...
Preoperative TIPS-Guided Portal Flow Modulation in RAPID Liver Transplantation: A New Step-Up Approach Supporting Hyper-Small Grafts [0.03%]
术前TIPS引导的肝移植供肝血流调节：一种支持超小移植物的新型序贯式方法
Mehdi Boubaddi,Florence Jeune,Chetana Lim et al.
Mehdi Boubaddi et al.
We report the case of a cirrhotic patient with significant portal hypertension (PHT) who underwent a RAPID procedure (Resection and Partial Liver Segment 2/3 Transplantation with Delayed Total Hepatectomy) using a hyper-small left liver gra...
Lung transplantation from a 94-year-old donor: a debate on biological versus chronological age [0.03%]
供肺来自94岁捐献者的肺移植：生物年龄与实际年龄的讨论
Jan Van Slambrouck,Cedric Vanluyten,Anabelle Decottignies et al.
Jan Van Slambrouck et al.
Lung transplantation (LTx) is challenged by a critical shortage of donors, prompting the extension of acceptance criteria, including donor age. Here, we report on a double-LTx from a 94-year-old donor. Despite the advanced age, the lungs we...
Lara C Pullen
Lara C Pullen
Sodium Glucose Co-transporter 2 Inhibitor Use after Heart Transplant: Current Knowledge and Potential Applications [0.03%]
心脏移植后钠葡萄糖共转运蛋白2抑制剂的应用：现状与潜在应用可能性
Lisa M Raven,Lina Brinker,Konstantinos Sideris et al.
Lisa M Raven et al.
Heart transplant (HTx) markedly improves survival and quality of life in patients with Stage D heart failure (HF). However, long-term survival post-HTx is limited by increased risk and progression of cardiovascular (CV) disease, chronic kid...
Editorial: Japan's Organ Donation Crisis is Structural, Not Cultural [0.03%]
编者按：日本的器官捐献危机是结构性的，而非文化性的
Mureo Kasahara,Seisuke Sakamoto
Mureo Kasahara
Reply to Liu, Zehui - Exploring the Potential of Machine Learning in Predicting Primary Graft Dysfunction Post-Lung Transplantation [0.03%]
刘泽慧来信回应 - 探讨机器学习在预测肺移植后原发性移植物功能障碍方面的潜力
Inez Oh,Ramsey R Hachem,Andrew P Michelson
Inez Oh
The Evolving Role of Liver Transplantation as Enzyme Replacement Therapy in the Era of RNA Nanotherapies [0.03%]
RNA纳米疗法时代肝移植作为酶替代治疗的作用演变
Eunice Tan,Nilah Ahimsadasan,Naomi Khaing Than Hlaing et al.
Eunice Tan et al.
Background/aims: Solid organ transplantation (SOT) is a treatment for monogenic diseases like transthyretin amyloidosis(ATTR) and primary hyperoxaluria(PH). The advent of RNA nanotherapy has introduced new disease-modifyi...